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The ICTS Translational Pathology and Molecular Phenotyping (TPMP) Core facilitates the collection, processing, 
storage, and genomic analysis of clinical specimens. The Core is directed by Mark A. Watson, MD, PhD, Associate 
Professor, Pathology and Immunology.
Among the various types of genomic analyses offered, microarray-based gene expression profiling, genotyping, and 
genome copy number analyses are performed using the Affymetrix GeneChip® system.  Together with the Siteman 
Cancer Center, the ICTS has supported several new enhancements to the facility to better integrate genomics with 
translational and clinical research.  These include:
•	 Added instrumentation for higher assay throughput.  With a total of 28 array processing stations and 
two array scanners, the facility is able to process the larger number of arrays required for conducting larger 
cohort, genome wide association studies.
•	 Implementation of policies and procedures for CAP accreditation and CLIA registration of assays.  The 
facility has completed all necessary steps for College of American Pathologist (CAP) laboratory accredita-
tion and has already registered one assay (Affymetrix SNP6.0 Genotyping Array) for clinical use in associa-
tion with the Washington University Clinical Cytogenomics Laboratory.  Similarly, other microarray- and 
non microarray-based assays can be developed and validated in a CLIA-registered, clinical laboratory envi-
ronment for use in specific, investigator-initiated clinical trials.
•	 Improved gene expression assays.  The facility has discontinued the use of the standard Affymetrix in 
vitro transcription (IVT) assay for performing gene expression array analysis using 3’ expression arrays 
I am pleased to announce that the Barnes-Jewish Hospital Foundation (BJHF) and the ICTS have issued the 
second annual call for proposals for the joint Clinical and Translational Research Funding Program.  Letters of 
Intent are due October 1st and proposals are due November 16th.  See the ICTS website (http://www.icts.wustl.
edu/funding/bjhf_icts_funding_program.aspx) for full details.  This year, as noted in the article on page 5, we 
will host a Town Hall meeting on Monday, September 14th to provide investigators the opportunity to discuss their 
questions with the pilot program directors, but you  can also email your questions to icts@wustl.edu.
The ICTS News is a key method of distributing information about the ICTS to our members, but in the last few 
months we have also been developing other communication channels.  We have added a calendar to our website 
(http://www.icts.wustl.edu/calendar/) that includes events such as the 2009 – 2010 Ethics Lecture Series and the 
events supported through our Clinical Research Training Center.  
We will also be distributing our new brochure to all ICTS members in the next month.  The brochure folds out 
into a poster that illustrates how all of our cores support the research cycle as well as easy reference contact infor-
mation for each.  In addition, in an effort to remind you to cite the CTSA grant in publications, the mailing will 
also include a magnet with the CTSA grant number for easy reference.  As we move into our third program year 
we continue to explore new avenues for increasing awareness about the value our cores can provide in supporting 
clinical and translational research, but communication is most productive if it is two way.  We are receptive to your 
comments and ideas and encourage you to provide feedback either through email to icts@wustl.edu, by calling 
the Administrative Core at 314-362-9829 or through the anonymous Feedback Forum available directly under the 
“News” updates on the front page of our website.
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(e.g. Human U133Plus2).  The assay has been replaced by a new method (3’ IVT Express) which is faster, 
cheaper, more robust, and can be used with as little as 25 ng of total cellular RNA without further molecular 
amplification.
•	 Whole transcriptome gene expression assays.  Using the ‘next generation’ of Affymetrix GeneChip® microar-
rays (Gene and Exon arrays) and NuGen® nucleic acid amplification chemistries, quantitative and qualitative 
(i.e. exon splicing) data can be reliably obtained from as little as 10 ng of total cellular RNA.  All new assays 
have been validated in the facility for robustness and reproducibility, and representative results comparing 
new and existing methods have been documented.
•	 Gene expres-
sion analysis from 
fixed or degraded 
biospecimens.  The 
facility has also test-
ed and validated the 
use of Affymetrix 
GeneChip® Exon and 
Gene arrays with 
NuGen® chemistry to 
obtain reliable and 
reproducible gene 
expression data from 
small quantities of 
degraded RNA, such 
is often obtained 
from formalin fixed 
tissue specimens, 
flow cytometry cell 
preparations, or other 
suboptimally collect-
ed clinical biospeci-
mens.  As shown 
in the accompany-
ing figure, standard 
Affymetrix chemistry 
(left) generates repro-
ducible and high quality data (reflected in array AUC values > 0.8) from a 200 ng reference RNA sample. 
The NuGen® assay (right) produces similar data from only 50 ng of the same reference sample.  Furthermore, 
using fixed (FFPE) and snap frozen pairs of two different tissue specimens, nearly comparable quality data 
was obtained (average array AUC of 0.85 vs. 0.75).  While data from fixed and frozen specimens is not directly 
comparable, technical reproducibility within frozen specimens (r=0.99) and fixed specimens (r=0.98) as a 
group was almost indistinguishable, demonstrating that reproducible array-based gene expression profiling 
studies can be performed on fixed and embedded tissue specimens, which are readily available in hospital 
surgical pathology departments.
•	 miRNA analysis.  The facility has tested and validated the Affymetrix GeneChip® assay for miRNA expression 
analysis.  The Affymetrix array provides probe sets to detect miRNAs from human, mouse, rat, and monkey 
genomes in addition to other human small nuclear RNAs, using as little as 0.1 ug of total cellular RNA.
Additional information regarding assay performance, costs (which are subsidized for ICTS members), and sample 
requirements can be found on the facility’s website:  http://pathology.wustl.edu/research/lcgicts.php or by 
contacting the facility by email (genechip@pathbox.wustl.edu) or phone (314-454-8520).
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The Pediatric Community Scientist Training and Research program, or C-STAR program, at Washington University and 
St. Louis Children’s Hospital is a new pediatric residency elective in clinical sciences training. C-STAR is part of the ICTS 
initiative in interdisciplinary career development and translational research in pediatrics supported by the NIH CTSA 
grant.  By providing pediatric residents the opportunity to perform clinical research under the guidance of a faculty 
mentor and advisory committee, the program seeks to narrow the gap between clinical trials and the pediatrician’s office 
and thus further the prevention and cure of pediatric disease.
Michael DeBaun, MD, MPH, the Ferring Family Chair in Pediatrics and Professor of Biostatistics and Neurology, directs 
the program.  Together with program co-directors Jane Garbutt, MB, ChB, FRCP (C), Director of the WU Pediatric and 
Adolescent Ambulatory Research Consortium (WU PAARC), and Katie Plax, MD, Medical Director of Pediatricians 
in Community program, they guide the scholars in planning their curriculum and creating a research project proposal. 
C-STAR participants have a specially designed schedule during the summer and fall of their third year of residency, 
including a two month community advocacy rotation.
The C-STAR scholars for 2009-2010 are Rebecca Papez, MD (pictured below, left), and Lisanne Palomar Newton, MD 
(pictured below, right).
Dr. Papez studied biochemistry as an undergraduate and attended medical school at the University of Nevada, where she 
was awarded the Roland W. Stahr Award for Excellence in Clinical Pediatrics.  In 2007 she began her residency in pediat-
rics at St. Louis Children’s Hospital.  Her current research is part of the Childhood Obesity Project, in which she studies 
the consumption of sugar-sweetened beverages by adolescents and the role that community pediatricians play in imple-
menting limited consumption of these products during health maintenance examinations.  
Dr. Palomar Newton studied biomedical engineering science, biology, and English at Washington University as an under-
graduate.  She attended Dartmouth Medical School and then came to Washington University Medical School, where she 
was awarded the Wynder Prize for Preventive Medicine in 2007.  Her current research works to identify early signs and 
symptoms of asthma exacerbations in children and the barriers to treatment. 
After their residency, C-STAR alumni will be encouraged to join WU PAARC and will have the opportunity to use the 
Department of Pediatrics’ Patient-Oriented Research Unit (PORU) and be part of the vibrant community of researchers 
within the Department of Pediatrics.  For more information about the C-STAR program and its requirements, please see 
the ICTS website (http://icts.wustl.edu/cores/cdtrp.aspx).
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Have You Met?              Yi Zhang
Yi Zhang, JD, RN, returned to Washington University July 1st as Assistant Dean 
for Clinical Trials, Operations Officer for the Center for Applied Research 
Sciences (CARS), and Co-Director of the ICTS Regulatory Support Core (RSC).  
CARS staff provide access to specialized clinical research services for investiga-
tors and, in conjunction with the RSC, assist investigators and their research 
teams in developing and conducting efficient, safe, and ethical studies.   In her 
new roles, Zhang plans, directs, and oversees clinical trial activities at the School 
of Medicine.
CARS is directed by Samuel Klein, MD, the William H. Danforth Professor of 
Medicine and Nutritional Science who helped recruit Yi to the position.  “We 
are very fortunate that Yi Zhang agreed to be the Operations Officer for CARS. 
Yi has a diverse background in law, business, clinical care and clinical research 
that make her exceptionally well-suited for this complex and challenging posi-
tion.  It is impressive how quickly she has grasped the major issues that need to 
be addressed in the CARS, and is developing creative and efficient approaches 
for how we conduct our business.”
Yi is returning to Washington University after leaving in 2008 to take a position in a large Chicago law firm where 
she specialized as a clinical research expert, advising clients such as Harvard and the University of Pittsburgh 
Medical Center.  “I thought a law firm environment would enable me to work for a more diverse group of clients, 
academic medical centers and regional hospitals alike, and felt I needed to do that for awhile.”  This spring WU was 
able to recruit Yi back.  “I am so happy to return to Washington University.  I missed the operational side of the 
business.  It is one thing to draft a comprehensive or bullet-proof contract or policy, but it is quite a different thing 
altogether to steer the ship.  The challenge is not conceptualizing the process but choreographing and operational-
izing it.”  
Yi attended Saint Louis University Law School, where she focused on health law, attending classes at night while 
running clinical trials, for example, a mitral valve replacement trial and a heart bypass surgery trial, at Washing-
ton University during the day.  After graduation she secured a position with Husch & Eppenberg, LLC, and her 
first assignment was to join a team of attorneys working with WU’s School of Medicine to negotiate clinical trial 
contracts and develop compliance processes.  “It must have been fate,” Yi says now.  After a year she accepted the 
position as the Director of Operations and Development for the Center of Clinical Studies.  
Yi grew up following in her parents footsteps.  Both her mother and father were physicians in Shanghai, China, 
where Yi spent her childhood.  Her father, who had taught himself English by listening to the Voice of America 
radio program during the tumultuous times of the Cultural Revolution, sought an opportunity through a govern-
ment grant to work in Norway.  He then made his way to England and connected with a Washington University 
physician who would go on to sponsor him and bring him to St. Louis.  At 17, with very little skill in English 
besides “book knowledge,” Yi found herself attending high school here.  Given she was still struggling with the 
language, she felt becoming a doctor would be a difficult path, so she entered nursing school at the University of 
Missouri-St. Louis.  After graduation, she worked at several area hospitals eventually becoming a cardiothoracic 
surgery ICU nurse.  “I loved it,” Yi said, “When we were fully staffed we were a well-oiled machine and the position 
gave me the autonomy and responsibility I desired.”  Yi crossed over to the corporate side of health care during the 
dot.com days, when she worked for a Mountain View, California medical device company and managed medical 
device clinical trials.  When the company’s venture funding faded, Yi decided to attend law school. 
Yi is married and has two children, a son -- her “strong-willed” child -- who is five, and a baby girl who is just three 
months and is happily the opposite – “sweet and easy-going.”  Their family was happy to return to St. Louis to be 
near her parents again and be working at WU.  For now, she is focused on streamlining business processes in CARS 
and working with our hospital partners to enhance our clinical trial compliance programs that will not add another 
layer of complexity and bureaucracy to the conduct of clinical research at the medical school. 
For questions about the Center for Applied Research Sciences (CARS) or to reconnect with Yi, contact her at 
314-362-6864 or yzhang@wusm.wustl.edu. 
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The Barnes-Jewish Hospital Foundation (BJHF) and the ICTS have again partnered to issue the second RFA for the 
Clinical and Translational Research Funding Program. The primary purpose of this program is to fund high-quality, 
innovative proposals that have the potential to advance human health.  Principal Investigators applying for this fund-
ing must be members of the ICTS.  Member eligibility information and registration is available at www.icts.wustl.edu.
Applications will be accepted in two categories: 
•	 Planning Grants: Provide up to $25,000 direct costs for 1 year to facilitate the planning of a new clinical or 
translational research project
•	 Research Grants: Provide up to $75,000 direct costs per year for 1-2 years to support a clinical or transla-
tional research project
A town hall meeting to provide investigators the opportunity to ask questions of the ICTS pilot program direc-
tors (Robert W. Thompson, MD, FACS, and Bradley A. Evanoff, MD, MPH) and obtain assistance in developing a 
competitive proposal will be held on Monday, September 14, 2009, from 2:00 – 3:00 p.m. in the classroom of the 
Clinical Research Training Center, 2 Wohl Clinic.
The full RFA can be accessed on the ICTS website at http://icts.wustl.edu/funding/bjhf_icts_funding_program.aspx. 
Important Dates:
•	 RFA Issue Date: August 3, 2009
•	 Town Hall Q&A Meeting: September 14, 2009 (2:00-3:00 p.m., CRTC Classroom)
•	 Letters of Intent Due: October 1, 2009
•	 Applications Due: November 16, 2009
•	 Proposal Peer Review: January, 2010
•	 Award Start Date: June 1, 2010
Questions may be addressed to icts@dom.wustl.edu, Becky Evans at 314-362-9386, Jaimee Stagner at 314-362-6325 
or Pamela Jayne at 314-286-0349.
Announcing the 2nd Annual BJHF/ICTS 
Clinical and Translational Research Funding Program
In the News
Want to know what lectures or events are coming up? 
Visit the new ICTS calendar
http://icts.wustl.edu/calendar/
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September 3 (8:00 a.m.) The Rena Schecter Memorial 
Lecture in Cancer Research, “Clinical and Translational 
Studies in Head and Neck Cancer at the University of 
Chicago,” with Everett E. Vokes, MD, Professor of Medi-
cine, Chairman, Department of Medicine, University of 
Chicago.  Clopton Auditorium, Wohl Hospital, Lower 
Level, 4960 Children’s Place .  Sponsored by the Siteman 
Cancer Center, Barnes Jewish Hospital and WU School 
of Medicine.   
September 8 (1:00–3:15 p.m.)  Career Development 
Lecture, “An Introduction to Economic Evaluation in 
Medicine,” with Steven M. Kymes, PhD.  ICTS Clinical 
Research Training Center (CRTC), 2nd Floor, Wohl 
Clinic. This presentation will introduce the basic con-
cepts and tools of economic evaluation.  Included will 
be how to construct an analysis, selection of the correct 
costs and measure of benefit, and construction of the 
decision models. 
September 23 (1:00–6:15 p.m.)   Institute for Public 
Health Second Annual Conference, “Multidisciplinary 
Approach to Eliminate Disparities.”  Eric P. Newman 
Education Center.  Keynote speakers include:
•	 Dr. Felton Earls, Professor of Behavior and Develop-
ment,  Harvard School of Public Health
•	 Dean Bruce Lindsey, Dean of the College of Ar-
chitecture  and Graduate School of Architecture & 
Urban Design, Sam Fox School of Design & Visual 
Arts, Washington University 
The conference will also include a panel discussion on 
“Solutions for Children, Youth, and Families,” and will 
be followed by a poster session and reception.  Visit 
the IPH website (http://publichealth.wustl.edu/news/
Pages/2009AnnualConference.aspx) for more informa-
tion and registration information. 
September 30 (4:00-6:00 p.m.) A reception for the 
Career Development Awards, Postdoctoral, Predoctoral 
and Doris Duke Programs. Clinical Research Training 
Center, 2nd Floor, Wohl Clinic.   RSVP by September 23 
to mfavazza@dom.wustl.edu or 314-454-8224.
October 28 (12:30-4:30 p.m.) ICTS Clinical Research 
Training Center 4th Annual Research Symposium and 
Poster Session.  Connor Auditorium, Farrell Learning 
and Teaching Center.  The symposium will include oral 
presentations and a poster session.
OUR COMMUNITY, OUR HEALTH CONFERENCE 
Community-Academic Partnerships to 
Reduce Health Disparities in St. Louis
Thursday, October 29, 2009 
8:30 a.m. – 1:00 p.m.  
Emerson Center at Harris Stowe State University 
Continental breakfast at 8:00 a.m. and lunch will be provided  
Our Community, Our Health is a joint program between 
Washington University and Saint Louis University that seeks to 
engage the St. Louis community in partnerships that address 
local health disparities.  
The conference will bring together citizens, community health 
and cultural leaders, community health professionals, and 
academic and medical researchers to address health disparity 
issues in our region and to align academic research priorities 
with community-identified health priorities.  This conference 
features a multifaceted program including: 
•	 A keynote address, “Community-Academic Partnerships: 
Essential to Addressing Health Disparities,” by Gloria 
Wilder, MD, MPH, nationally acclaimed pediatrician and 
anti-poverty activist.  http://www.corehealthdc.com/aboutus.
html
•	 A report on Community-Identified Health Priorities
•	 Presentations from local community organizations and 
researchers on Success Stories of Community-Academic 
Partnerships
The conference is free and open to the public but registration is requested
Click Here to Register
Our Community, Our Health is directed by Consuelo H. 
Wilkins, MD, of Washington University and co-directed by 
Darcell P. Scharff, PhD, of Saint Louis University.   
The series is funded by Washington University’s 
Institute of Clinical and Translational Sciences 
and Washington University’s Center for Health Policy 
For more information about the conference visit the  
Our Community, Our Health website
Fall Conferences
ICTS Bander Program in Business Ethics  
in Medical Research
Thursday, November 5, 2009 Lecture  
3:30-4:30 p.m. 
Connor Auditorium 
Farrell Learning and Teaching Center 
Washington University Medical School Campus 
(Reception in Atrium beginning at 3:00 p.m.)
“Conflicts of Interest in Academic Medicine:  
Where We Were, Where We Are, and  
Where We Might Be Headed” 
William M. Sage, MD, JD  
Vice Provost for Health Affairs and James R. Doherty Chair for 
Faculty Excellence in Law, University of Texas at Austin
RSVP by October 31 to 314-362-9829 or icts@wustl.edu
